Last checked at 
| Friday 12 June |
| Katoro Gold |
| Informa |
| Bakkavor |
| Capital Drilling |
| Monday 15 June |
| IQ-AI |
| Mirriad Advertising |
| Tuesday 16 June |
| Marshall Motor |
| Clearstar |
| Epwin Group |
| Coca-Cola HBC |
| Science Group |
| Altus Strategies |
| Arbuthnot Banking |
| Evraz |
| Andrews Sykes Group |
| FDM Group |
| Wednesday 17 June |
| Amigo Holdings (re board removal) |
| RTC Group |
| Wentworth Resources |
| STM Group |
| Salt Lake Potash |
| Domino's Pizza Group |
| Pelatro |
| UK Oil & Gas |
| G4S |
| Thursday 18 June |
| Ted Baker (re share placing) |
| IP Group |
| Horizon Discovery |
| Ten Entertainment |
| Shield Therapeutics |
| Tremor International |
| Jadestone Energy |
| Vietnam Enterprise |
| Intelligent Ultrasound Group |
| Block Energy |
| RBG Holdings |
| Impact Healthcare |
| Michelmersh |
| Immupharma |
| Copyright 2020 Alliance News Limited. All Rights Reserved. |
4 Nov 2015 10:44
ImmuPharma's Lupuzor trial on track for 2017 completion
(ShareCast News) - ImmuPharma has reached a number of important milestones in the phase three clinical trial of Lupuzor. The AIM listed company provided an update to the market on Wednesday about the drug trial, its lead programme for the potential breakthrough compound for life threatening auto imm
Read more